A growing share of products sold as kratom contain semi-synthetic opioids that do not occur in the plant at all. Knowing which is which changes what withdrawal looks like and how dangerous it is to stop alone.
Somebody buys a bottle off a shelf on GA-54, reads the word kratom, and reasonably concludes it is a plant product. That was a defensible assumption a few years ago. It is not any more. The category now includes concentrated extracts and lab-made compounds that share a family tree with the leaf and behave in the body like prescription opioids, and the label is frequently no help at all in telling them apart.
Peachtree Detox & Residential provides medically supervised kratom detox in Fayetteville, and the people arriving for it have changed alongside the products. Ten years ago the story was a leaf tea used for energy or pain. Now it is often a small concentrated tablet or shot that produced a physical dependence far faster than anybody expected. Whether you are the person doing the reading or the parent who found the bottles, the useful thing is being able to tell what you are actually dealing with.
Mitragynine, 7-OH, and the Compounds the Plant Never Made
The kratom leaf contains dozens of alkaloids, naturally occurring plant chemicals with drug-like effects. Mitragynine is the main one. A second, 7-hydroxymitragynine, usually shortened to 7-OH, occurs naturally only in trace amounts, under 2 percent of total alkaloid content, and it is considerably more potent at the opioid receptor than mitragynine is.
Two things about that matter enormously. The first is that 7-OH can be produced from mitragynine in a single-step reaction, and lab-made 7-OH is chemically identical to the trace amount in the leaf. The second is that in whole leaf, the other alkaloids compete with 7-OH and blunt its effect, while an isolated concentrate has nothing holding it back. Federal regulators describe concentrated 7-OH as having opioidergic activity with a profile similar to Schedule II opioids such as morphine, and the FDA has put its potency at roughly 13 times that of morphine.
Then there is the newer group, the reason this page exists. Mitragynine pseudoindoxyl, MGM-15, and MGM-16 are semi-synthetic compounds that do not occur naturally in the plant at any level. They are made in a lab from kratom alkaloids. In July 2026 the Drug Enforcement Administration moved to place all three temporarily into Schedule I. The potency figures attached to them come from animal and preclinical work rather than human dosing studies, and they should be read that way: mitragynine pseudoindoxyl has been reported at roughly 100 times the potency of mitragynine at the mu-opioid receptor, with MGM-15 around 50 times and MGM-16 around 240 times morphine in animal models.
None of those numbers translate directly to a human dose. What they establish is category. These are opioids, engineered ones, sold in a section of the store that most people read as supplements.
Why the Label Is Not Going to Tell You
The practical problem for a family is that the packaging is designed to reassure rather than inform. A bottle may say kratom, or list a botanical name, or advertise an extract strength as a multiplier with no reference point. It may not disclose 7-OH content at all. Products showing up as tablets, gummies, drink mixes, and small shots are being sold online and at smoke shops and gas stations, and the FDA has been explicit that no 7-OH product is approved for any use.
Which leaves a person guessing about the single most important variable. The gap between a cup of leaf tea and a concentrated 7-OH tablet is not a difference of degree; it is the difference between a mild opioid-like effect and something that produces dependence in weeks. People frequently reach for these products to self-treat anxiety, low mood, pain, or, in a bitter loop, opioid withdrawal, and reported effects include addiction, anxiety, depression, gastrointestinal distress, insomnia, seizures, and a withdrawal syndrome of its own.
If you are trying to work out what someone has been taking, the useful questions are how often, in what form, and for how long, rather than what the bottle claims. Frequency and form tell you far more about the physical dependence than the branding does.
Where Georgia Law Actually Stands
Georgia is further ahead on this than most states, which is worth knowing because it changes what is legal to sell in Fayette and Coweta counties right now.
Georgia’s Kratom Consumer Protection Act took effect January 1, 2025. Under O.C.G.A. § 16-13-122, a product may contain no more than 150 milligrams of mitragynine per serving, no more than 0.5 milligrams of 7-OH per gram, and no more than 1 milligram of 7-OH per serving. The law prohibits synthetic alkaloids, including synthetic 7-OH, requires 21-and-over age verification and behind-the-counter placement, sets labeling requirements, and bans kratom vape and e-cigarette products.
Read against the previous section, that means a product containing mitragynine pseudoindoxyl or a concentrated synthetic 7-OH is already outside Georgia law. It also means the presence of a product on a shelf is not evidence that it complies. The state Attorney General has issued a consumer alert about synthetic opioids turning up in gas stations, and the federal scheduling action arrived on top of the state framework rather than instead of it.
Nothing here is legal advice, and none of it is meant to frighten anyone away from getting help. It matters clinically for one reason: a person who has been taking a product they believed was an herbal supplement is often carrying real shame and real confusion when the withdrawal turns out to be opioid withdrawal. Knowing the pharmacology takes some of that weight off.
What Withdrawal Actually Looks Like
Because these compounds act at the opioid receptor, stopping them produces opioid withdrawal, and the shape is recognizable to any clinician who has treated it: watering eyes and runny nose, goosebumps, deep muscle and bone aches, diarrhea, nausea and vomiting, dilated pupils, sensitivity to light, insomnia, yawning, and a nervous system running hot. It comes from the locus coeruleus, a small brainstem region that opioids suppress and that rebounds hard when they are removed.
Opioid withdrawal on its own is rarely fatal, which is a fact people misuse. It is nonetheless severe enough that a large share of people stop trying and use again just to make it stop, and that return to a previous dose after tolerance has dropped is the single most dangerous moment in the entire cycle. Seizures have also been reported with these products specifically, which puts a home taper on a different footing than an ordinary opioid taper.
Poison-center data from January through July of 2025 recorded 165 exposures involving these compounds, with 35 percent classified as serious harm and 67 percent treated at a health care facility. If you think somebody is in immediate danger, the Georgia Poison Center answers 24 hours a day at 1-800-222-1222.
Why Medically Supervised Detox Is the Sane Choice Here
A supervised opioid detox exists to lower two risks at once: the medical risk of the withdrawal itself, and the far larger practical risk that someone gives up on day three and returns to a dose their body can no longer handle.
On an inpatient unit, symptoms get treated as they arrive rather than endured. Comfort medications address the nausea, the sleep, the agitation, and the muscle pain. Vital signs are monitored around the clock by nursing staff, which matters most overnight, when withdrawal typically worsens and a person is least able to advocate for themselves. Where it is clinically appropriate, medication-assisted treatment is part of the plan; Suboxone and Sublocade are buprenorphine-based, and Vivitrol is an injectable naltrexone that works by the opposite mechanism. Which one fits, and when it can safely be started, is a prescriber’s decision made for the individual person and not something to work out from a web page.
It would be dishonest to suggest clearing the compound is the finish line. Detox stabilizes the body. What holds afterward is built in the step that follows, which is why the move from detox into residential care is planned during the stay rather than improvised at discharge. A great many people who arrive for this were medicating something underneath, and trauma therapy and cognitive behavioral therapy get at that rather than leaving it in place.
What This Means Around South Metro Atlanta
Fayetteville sits at the end of a corridor that makes these products easy to buy. GA-54 and GA-85 run past the shops, I-85 and I-75 bring the supply into the metro, and Hartsfield-Jackson is 25 minutes north. Families in Fayetteville, Peachtree City, Newnan, Tyrone, and Jonesboro have been describing the same sequence to us for two years now: a product bought openly, taken for pain or energy or sleep, and a dependence that arrived faster and hit harder than a plant supplement had any business doing.
If that sounds like your household, the confusion is the normal reaction rather than a sign you missed something obvious. The category genuinely changed underneath everybody, and the labeling did not keep up.
Getting Off It Safely, Starting in Fayetteville
If you are somewhere in the first days of trying to stop, or watching somebody try, the next stretch does not have to look like the version you are bracing for. Peachtree Detox & Residential is at 1008 GA-54 in Fayetteville, with nursing coverage on the unit around the clock and medication to bring withdrawal down to something manageable. Bring the bottle with you if you still have it; knowing what was actually in it helps the medical team plan. Reach out through our admissions page and we will talk through what an admission involves and go over your benefits, whichever side of this you are calling from. If someone is in immediate danger, the Georgia Poison Center answers 24 hours a day at 1-800-222-1222, and 911 comes first in an emergency.
Frequently Asked Questions About Pseudo-Kratom and Mitragynine Pseudoindoxyl
Kratom is the leaf, whose main alkaloid is mitragynine. 7-OH occurs naturally in the leaf only in trace amounts, under 2 percent of alkaloid content, but can be made from mitragynine in a single-step reaction and concentrated, at which point regulators compare its activity to Schedule II opioids like morphine. Mitragynine pseudoindoxyl, along with MGM-15 and MGM-16, is semi-synthetic and does not occur in the plant at any level. The DEA moved to place all three temporarily into Schedule I in July 2026.
Georgia’s Kratom Consumer Protection Act took effect January 1, 2025. It caps mitragynine at 150 milligrams per serving and 7-OH at 0.5 milligrams per gram and 1 milligram per serving, prohibits synthetic alkaloids including synthetic 7-OH, requires 21-and-over sales and behind-the-counter placement, and bans kratom vapes. A product containing mitragynine pseudoindoxyl or concentrated synthetic 7-OH falls outside that law. Being on a shelf is not evidence a product complies, and nothing here is legal advice.
It is riskier than most people expect with these products specifically. Opioid withdrawal is rarely fatal by itself, but seizures have been reported with concentrated kratom-derived compounds, and the far bigger danger is stopping the taper on day three and returning to a dose your body no longer tolerates. That drop in tolerance is where overdoses happen. A supervised detox treats symptoms as they arrive and keeps someone monitored overnight, when withdrawal usually worsens and a person is least able to speak up for themselves.
Peachtree Detox & Residential is in-network with TRICARE East, Select and Prime, which makes it a straightforward option for military families across the south metro. For other plans, our team verifies your specific benefits and tells you what your coverage actually looks like before anyone is admitted, rather than leaving you to decode it from a benefits letter. Private-pay arrangements are also available. Asking what something costs is a normal first question and it does not commit you to anything.
Sources
- Drug Enforcement Administration. (2026, July 6). Schedules of controlled substances: Temporary placement of mitragynine pseudoindoxyl, MGM-15, and MGM-16 in schedule I. 91 FR 40909. Retrieved from: https://www.federalregister.gov/documents/2026/07/06/2026-13581/schedules-of-controlled-substances-temporary-placement-of-mitragynine-pseudoindoxyl-mgm-15-and. Accessed on September 17, 2026.
- Drug Enforcement Administration. (2026, July 6). Schedules of controlled substance: Temporary placement of 7-hydroxymitragynine above a specified threshold in schedule I. 91 FR 40917. Retrieved from: https://www.federalregister.gov/documents/2026/07/06/2026-13580/schedules-of-controlled-substance-temporary-placement-of-7-hydroxymitragynine-above-a-specified. Accessed on September 17, 2026.
- U.S. Food and Drug Administration. (n.d.). Products containing 7-OH can cause serious harm. Retrieved from: https://www.fda.gov/consumers/consumer-updates/products-containing-7-oh-can-cause-serious-harm. Accessed on September 17, 2026.
- Georgia Office of the Attorney General. (2025, November 13). Consumer alert: Carr warns of dangerous synthetic opioids flooding gas stations. Retrieved from: https://law.georgia.gov/press-releases/2025-11-13/consumer-alert-carr-warns-dangerous-synthetic-opioids-flooding-gas. Accessed on September 17, 2026.
- National Institute on Drug Abuse. (n.d.). Kratom. Retrieved from: https://nida.nih.gov/research-topics/kratom. Accessed on September 17, 2026.
- Shah, M., & Huecker, M. R. (2023). Opioid withdrawal. StatPearls. Retrieved from: https://www.ncbi.nlm.nih.gov/books/NBK526012/. Accessed on September 17, 2026.
